Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2025	Mar. 31, 2024	Mar. 31, 2025	Mar. 31, 2024
Income Statement [Abstract]
Revenue	$ 0	$ 0	$ 7,894	$ 0
Cost of revenue	60,111	0	166,022	0
Gross profit	(60,111)	0	(158,128)	0
Operating expenses:
Research and development expenses	40,564	0	128,564	0
General and administrative expenses	459,362	199,991	2,884,783	835,123
Total operating expenses	499,926	199,991	3,013,347	835,123
Loss from Operations	(560,037)	(199,991)	(3,171,475)	(835,123)
Other income (expense):
Interest expense	(973)	(440)	(4,146)	(1,147)
Other income	184	453	186	1,989
Total other income (expense)	(789)	13	(3,960)	842
Net loss	(560,826)	(199,978)	(3,175,435)	(834,281)
Noncontrolling interest	(6,118)	(8,033)	(15,869)	(9,275)
Net loss attributable to GenFlat Holdings, Inc.	$ (554,708)	$ (191,945)	$ (3,159,566)	$ (825,006)
Loss per share - basic attributable to GenFlat Holdings, Inc.	$ (0.05)	$ (0.00)	$ (0.30)	$ (0.00)
Loss per share - diluted attributable to GenFlat Holdings, Inc.	(0.05)	(0.00)	(0.30)	(0.00)
Loss per share - basic attributable to noncontrolling interest	(0.00)	(0.00)	(0.00)	(0.00)
Loss per share - diluted attributable to noncontrolling interest	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Weighted average common shares outstanding - basic	10,700,760	10,541,500	10,628,883	10,475,623
Weighted average common shares outstanding - diluted	10,700,760	10,541,500	10,628,883	10,475,623